Neuren Pharmaceuticals | NEU - Cost Of Sales



Neuren Pharmaceuticals reported 894K in Cost of Sales for its fiscal semester ending in June of 2024.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
Avita Medical AUD 2.28M 170K Dec/2024
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Genetic Signatures AUD 4.63M 526K Dec/2024
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
Medical Developments International AUD 5.27M 2.92M Dec/2024
Organon & Co USD 720M 48M Jun/2025
Paradigm Biopharmaceuticals AUD 18.72K 9.73K Dec/2024
PYC Therapeutics AUD 3.1M 2.8M Dec/2020
Starpharma Holdings AUD 348K 2.26M Dec/2024
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025